All Articles
Filters
Psychedelics
Big Pharma Is Making Another Move Into Psychedelic Drug Development
Pharmaceutical giant AbbVie (NYSE: ABBV) has announced a new partnership with psychedelic drug developer Gilgamesh Pharmaceuticals to develop psychedelic drugs.
May 13, 2024
Biotech
Public Companies
Nuclear
Oklo Is Bringing Nuclear Power To The NYSE
Nuclear power company Oklo (NYSE:OKLO) has officially gone public after completing their SPAC transaction with AltC Acquisition Corp.
May 13, 2024
General
IPO
Nuclear
Public Companies
Artificial Intelligence
Dubai Is Building The World’s Largest Autonomous Trucking Network
Autonomous trucking startup Einride has partnered with Jebel Ali Port in Dubai to build the world’s largest autonomous trucking network.
May 13, 2024
Artificial Intelligence
Electric Vehicles
Regulatory
Mining
The Department of Energy and Talon Metals Want To Turn Mining Waste Into New Battery Production
The United States Department of Energy's Argonne National Laboratory announced a new partnership with Talon Metals (TSX:TLO) for EV inputs from mining waste.
May 12, 2024
Regulatory
Public Companies
Electric Vehicles
Crypto
NFT Merchandise Is Becoming Big Business For The Largest Retailers in America
Popular NFT collection Pudgy Penguins has announced they have sold 1 million physical units of their Pudgy Penguins toy collection.
May 12, 2024
NFT
General
Mining
BHP And Ivanhoe Electric Want To Find More American Copper
Mining giant BHP (NYSE: BHP) and Ivanhoe Electric (NYSE: IE) have announced a new joint venture partnership focused on finding new copper deposits in the US.
May 10, 2024
Regulatory
Electric Vehicles
Biotech
Novo Nordisk Is All In On Weight Loss Drugs
Novo Nordisk (NASDAQ:NVO) has announced a new $600 million collaboration with Metaphore Biotechnologies to develop two new weight loss drug candidates.
May 10, 2024
Public Companies
Biotech
Psychedelics
Compass Pathways Is On The Verge Of Another Psychedelic Breakthrough
Psychedelic drug developer Compass Pathways (NASDAQ:CMPS) has announced early clinical validation for their novel synthetic psilocybin compound.
May 9, 2024
Biotech
Psychedelics
Public Companies
Regulatory
Discover the world's most disruptive early stage companies with 25,000+ investors.
The markets and trends that matter, made simple.
Join top talent at the world's most respected institutions, companies, and venture capital funds.